Advertisement

Symptom Management for Patients with Brain Tumors: Improving Quality of Life

  • Allen W. Burton
  • Tracy L. Veramonti
  • Phillip C. Phan
  • Jeffrey S. Wefel
Part of the M. D. Anderson Cancer Care Series book series (MDCCS)

Keywords

Brain Tumor Cancer Pain Spinal Cord Stimulation Brain Tumor Patient Neurocognitive Functioning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  1. Anderson SW, Damasio H, Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 1990;47:397–405.PubMedGoogle Scholar
  2. Brain Tumor Progress Review Group. Report of the Brain Tumor Progress Review Group. NIH Publication No. 01–. National Cancer Institute and National Institute of Neurological Disorders and Stroke; 2000. Available at: http://planning.cancer.gov/pdfprgreports/2000braintumor.pdf.
  3. Burton AW, Rajagopal A, Shah HN, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 2004;5:239–247.PubMedCrossRefGoogle Scholar
  4. Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. [Review] Oncology (Huntingt) 1998;12:369–377.Google Scholar
  5. Chan AS, Cheung M, Law SC, Chan JH. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 2003;100:398–404.CrossRefGoogle Scholar
  6. Cicerone KD, Dahlberg C, Kalmar K, et al. Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehab 2000;81: 1596–1615.CrossRefGoogle Scholar
  7. Clohisy DR, Mantyh PW. Bone cancer pain. Cancer 2003;97:866S–873S.CrossRefGoogle Scholar
  8. Crossen JR, Garwood D, Glatstein E, Neuwalt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627–642.PubMedGoogle Scholar
  9. Fourney DR, Schomer DF, Nader R, et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003;98:21–30.PubMedCrossRefGoogle Scholar
  10. Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S. Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 1996;41:55–59.PubMedGoogle Scholar
  11. Hara H, Kato H, Kogure K. Protective effect of a-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res 1990;510:335–338.PubMedCrossRefGoogle Scholar
  12. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcome after brain tumor and acute stroke: a comparative analysis. Arch Phys Med Rehab 1998;79:1386–1390.CrossRefGoogle Scholar
  13. Huang ME, Wartella JE, Kreutzer JS. Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch Phys Med Rehab 2001;82: 1540–1546.CrossRefGoogle Scholar
  14. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. New York, NY: Oxford University Press, 2004.Google Scholar
  15. Litofsky NS, Farace E, Anderson F, et al. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 2004;54:358–367.PubMedCrossRefGoogle Scholar
  16. Lovely MP. Symptom management of brain tumor patients. Semin Oncol Nurs 2004;20:273–283.PubMedCrossRefGoogle Scholar
  17. Meyers CA. Issues of quality of life in neuro-oncology. In: Vecht CJ, ed. Handbook of Clinical Neurology, Neuro-Oncology, Part I. Brain Tumors: Principles of Biology, Diagnosis and Therapy. Vol. 23. Amsterdam, The Netherlands: Elsevier Science BV; 1997:389–409.Google Scholar
  18. Meyers CA. Neuropsychological deficits in brain tumor patients: effects of location, chronicity, and treatment. Cancer Bull 1986;38:30–32.Google Scholar
  19. Meyers CA, Abbruzzese JL. Cognitive functioning in cancer patients: effect of previous treatment. Neurology 1992;42:434–436.PubMedGoogle Scholar
  20. Meyers CA, Hess KR, Yunk WKA, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000;18: 646–650.PubMedGoogle Scholar
  21. Meyers CA, Kudelka AP, Conrad CA, Gelke CK, Grove W, Pazdur R. Neurotoxicity of CI-980, a novel mitotic inhibitor. Clin Cancer Res 1997;3: 419–422.PubMedGoogle Scholar
  22. Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 2003;21:3557–3558.PubMedCrossRefGoogle Scholar
  23. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522–2527.PubMedGoogle Scholar
  24. Nasir S. Modafinil improves fatigue in primary brain tumor patients. [Abstract] Neuro-oncol 2003;5:335.Google Scholar
  25. National Comprehensive Cancer Network. Cancer-Related Fatigue. NCCN Practice Guidelines in Oncology version 1.2006. National Comprehensive Cancer Network; 2006. Available at: http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf.
  26. O'Dell MW, Barr K, Spanier D, Warnick RE. Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehab 1998;79: 1530–1534.CrossRefGoogle Scholar
  27. Rapp SR, Rosdhal R, D'Agostino RB, et al. Improving cognitive function in brain irradiated patients: a phase II trial of an acetylcholinesterase inhibitor (donepezil). [Abstract] Neuro-oncol 2004;6:357.Google Scholar
  28. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 1996;30:61–69.PubMedCrossRefGoogle Scholar
  29. Sherer M, Meyers CA, Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer 1997;80:250–257.PubMedCrossRefGoogle Scholar
  30. Sherman AM, Jaeckle K, Meyers CA. Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease. Cancer 2002;15:1311–1316.CrossRefGoogle Scholar
  31. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. [Review] Lancet Neurol 2004;3:159–168.PubMedCrossRefGoogle Scholar
  32. Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 2000;47:324–333.PubMedCrossRefGoogle Scholar
  33. Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 2004;90:1691–1696.PubMedGoogle Scholar
  34. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 1995;75:1151–1161.Google Scholar
  35. Yoshida S, Busto R, Watson BD, Santiso M, Ginsberg MD. Postischemic cerebral lipid peroxidation in vitro: modification by dietary vitamin E. J Neurochem 1985;44:1593–1601.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Allen W. Burton
  • Tracy L. Veramonti
  • Phillip C. Phan
  • Jeffrey S. Wefel

There are no affiliations available

Personalised recommendations